PCT Blend 50mg / 25mg – 60 Capsules

Introduction

The PCT Blend 50mg / 25mg capsules offered by Axiocent represent a research-use-only (RUO) compound formulated specifically for laboratory and analytical research applications. This blend combines two distinct biochemical agents, Laxogenin and Armistane, encapsulated in a standardized capsule format. Each capsule contains 50mg of Laxogenin and 25mg of Armistane, provided in a package of 60 capsules. The product is designed to support experimental investigations into hormonal pathways and related biochemical processes within controlled research environments.

Scientific and Research Context

Laxogenin is a plant-derived steroidal compound frequently utilized in biochemical research for its structural properties related to steroidal frameworks. Armistane, a steroidal aromatase inhibitor analog, is employed in research settings to study enzymatic pathways involving steroid metabolism. The combination of these compounds in a blend allows researchers to explore complex interactions within hormonal and enzymatic systems, particularly in vitro or in silico experimental models. This product is strictly intended for non-clinical research and analytical purposes, with no implication or authorization for human or veterinary use.

Laboratory Applications

Within laboratory environments, the PCT Blend 50mg / 25mg capsules are utilized primarily in experimental frameworks focusing on hormonal regulation, enzymatic inhibition studies, and biochemical pathway modeling. Researchers may incorporate this blend into cell culture assays, receptor binding studies, or analytical chemistry protocols to investigate the molecular interactions and stability of steroidal compounds. The capsule format facilitates precise dosing in experimental setups requiring consistent compound delivery. This product supports a range of non-clinical research methodologies including chromatographic analysis, mass spectrometry profiling, and receptor affinity assays.

Product Specifications

• Strength: 50mg Laxogenin / 25mg Armistane per capsule
• Format: Capsules
• Quantity: 60 capsules per package
• Storage Conditions: Store in a cool, dry place away from direct light to maintain compound integrity
• Handling Details: Use appropriate laboratory safety protocols including gloves and protective equipment when handling
• Batch and Quality Control: Supplied with batch-specific documentation ensuring consistency and traceability for research use

Handling and Laboratory Protocol Notes

To preserve the stability and purity of the PCT Blend, it is recommended to store the capsules under controlled temperature conditions, avoiding exposure to moisture and light. Handling should be conducted in accordance with standard laboratory safety procedures, including the use of personal protective equipment. Preparation for experimental use may involve capsule content extraction under sterile conditions, ensuring accurate compound measurement for analytical or experimental protocols. Researchers should consult material safety data sheets (MSDS) and institutional guidelines for detailed handling instructions.

Key Features

• Research-use-only (RUO) compound blend combining Laxogenin and Armistane
• Capsule format for precise compound delivery in laboratory settings
• Standardized strength of 50mg / 25mg per capsule
• Supplied in a package of 60 capsules with batch-specific quality control
• Suitable for biochemical, enzymatic, and hormonal pathway research
• Storage and handling protocols designed to maintain compound stability

Related Research Areas

This product is relevant to research domains involving steroidal biochemistry, enzymatic inhibition studies, and hormonal pathway analysis. Adjacent compounds and categories include other steroidal analogs, aromatase inhibitors, and plant-derived steroidal compounds utilized in biochemical research. Researchers investigating receptor binding, enzymatic activity modulation, or steroid metabolism pathways may find this blend applicable within their experimental frameworks.

Conclusion

The PCT Blend 50mg / 25mg capsules by Axiocent provide a reliable, quality-controlled resource for research-use-only applications in laboratory and analytical settings. The combination of Laxogenin and Armistane in a standardized capsule format supports detailed experimental investigations into steroidal and enzymatic pathways. Axiocent maintains rigorous quality assurance and batch consistency to meet the demands of scientific research environments.

Compliance Disclaimer

For research use only. Not for human or veterinary use. Not intended for medical, therapeutic, or diagnostic purposes.